Clinic of Anesthesiology and Intensive Care, Health Sciences University Dr. Lutfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey -
Clinic of Anesthesiology and Intensive Care, Health Sciences University Dr. Lutfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey.
Minerva Anestesiol. 2021 May;87(5):604-612. doi: 10.23736/S0375-9393.20.15015-6. Epub 2020 Dec 17.
A novel Coronavirus was identified in late 2019 as the cause of COVID-19 disease which is highly contagious. SARS-CoV-2 is a single-stranded RNA, enveloped virus from the beta Coronavirus family. Intraoperative management of patients with COVID-19 is a high-risk procedure. An international attention has raised to develop recommendations for the management strategies. This review article was designed to synthesize the existing evidence and experience related to intraoperative management of COVID-19. This review provides a summary of clinical guidance and addresses six domains: principles of intraoperative monitoring, airway management and related difficulties, ventilation, type of anesthesia, medications and side effects, and intraoperative fluid management.
一种新型冠状病毒于 2019 年末被确定为 COVID-19 疾病的病因，该病毒具有高度传染性。SARS-CoV-2 是一种来自β冠状病毒科的单链 RNA、包膜病毒。COVID-19 患者的术中管理是一项高风险的程序。国际社会高度关注制定管理策略的建议。这篇综述文章旨在综合与 COVID-19 术中管理相关的现有证据和经验。这篇综述提供了临床指导的总结，并涉及六个领域：术中监测原则、气道管理和相关困难、通气、麻醉类型、药物和副作用，以及术中液体管理。
